Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://tessalgc905015.wikipowell.com/6797939/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment